Arena Pharmaceuticals, Inc.
NASDAQ: ARNA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Amit Munshi
- Employees
- 448
- Headquarters
- San Diego, United States
- IPO year
- 2000
- Website
- https://www.arenapharm.com
Loading ARNA…
Loading profile data…Frequently asked questions about ARNA
What does Arena Pharmaceuticals, Inc. (ARNA) do?
Arena Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing innovative therapeutic agents, specifically designed with distinct pharmacological and pharmacokinetic profiles, for a global patient population. Its extensive pipeline features several key investigational medicines. Etrasimod (APD334) is undergoing diverse clinical...
Where does ARNA trade?
Arena Pharmaceuticals, Inc. (ARNA) trades on the NASDAQ Global Select.
What sector is ARNA in?
Arena Pharmaceuticals, Inc. (ARNA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Arena Pharmaceuticals, Inc.?
Amit Munshi is the chief executive officer of Arena Pharmaceuticals, Inc. (ARNA).
Where is Arena Pharmaceuticals, Inc. headquartered?
Arena Pharmaceuticals, Inc. is headquartered in United States.
Does ARNA pay a dividend?
Arena Pharmaceuticals, Inc. (ARNA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ARNA go public?
Arena Pharmaceuticals, Inc. (ARNA) completed its initial public offering in 2000.